Taylor & Francis Group
Browse
1/1
2 files

PTENα regulates mitophagy and maintains mitochondrial quality control

Version 2 2020-04-09, 07:03
Version 1 2018-08-01, 17:02
dataset
posted on 2020-04-09, 07:03 authored by Guoliang Li, Jingyi Yang, Chunyuan Yang, Minglu Zhu, Yan Jin, Michael A. McNutt, Yuxin Yin

PTEN plays an important role in tumor suppression, and PTEN family members are involved in multiple biological processes in various subcellular locations. Here we report that PTENα, the first identified PTEN isoform, regulates mitophagy through promotion of PARK2 recruitment to damaged mitochondria. We show that PTENα-deficient mice exhibit accumulation of cardiac mitochondria with structural and functional abnormalities, and PTENα-deficient mouse hearts are more susceptible to injury induced by isoprenaline and ischemia-reperfusion. Mitochondrial clearance by mitophagy is also impaired in PTENα-deficient cardiomyocytes. In addition, we found PTENα physically interacts with the E3 ubiquitin ligase PRKN, which is an important mediator of mitophagy. PTENα binds PRKN through the membrane binding helix in its N-terminus, and promotes PRKN mitochondrial translocation through enhancing PRKN self-association in a phosphatase-independent manner. Loss of PTENα compromises mitochondrial translocation of PRKN and resultant mitophagy following mitochondrial depolarization. We propose that PTENα functions as a mitochondrial quality controller that maintains mitochondrial function and cardiac homeostasis.

Abbreviations: BECN1 beclin 1; CCCP carbonyl cyanide m-chlorophenylhydrazone; FBXO7 F-box protein 7; FS fraction shortening; HSPA1L heat shock protein family A (Hsp70) member 1 like; HW: BW heart weight:body weight ratio; I-R ischemia-reperfusion; ISO isoprenaline; MAP1LC3/LC3 microtubule associated protein 1 light chain 3; MBH membrane binding helix; MFN1 mitofusin 1; MFN2 mitofusin 2; Nam nicotinamide; TMRM tetramethylrhodamine ethyl ester; WGA wheat germ agglutinin

Funding

This work was supported by the following grants to Y. Yin, including: National Key Research and Development Program of China (Grant #2016YFA0500302), National Natural Science Foundation of China (Key grants #81430056, #31420103905, #81372491 and #81621063), Beijing Natural Science Foundation (Key grant #7161007), and Lam Chung Nin Foundation for Systems Biomedicine.

History